Hollings Renton, Director at ANAPTYSBIO, INC (ANAB), sold 10,000 shares at $25.00 ($250K) on 2024-11-29, disclosed to the SEC on 2024-12-03.
Scheduled sale ($250k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ANAB | SELL | 2025-06-20 | $145K | — | Filing → |
| ANAB | SELL | 2024-07-17 | $613K | — | Filing → |
| ANAB | SELL | 2024-06-18 | $45K | — | Filing → |